PERSPECTA

News from every angle

Back to headlines

Eli Lilly (LLY) Reports Q1 2026 Revenue Surge of 56% Following FDA Approval of Foundayo

7 May, 04:57 — 7 May, 04:57
PostShare

Sources

Showing 1 of 1 sources